Item 5. Other Information

The following table describes contracts, instructions or written plans for the sale or purchase of our securities adopted or terminated by our directors or officers during the first quarter of fiscal 2026 that are intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act (Rule 10b5-1 trading arrangement).


Name and Title			Action			Date of Adoption/ Termination			Duration of Rule 10b5-1 Trading Arrangement			Aggregate Number of Securities to Be Purchased or Sold
Vincent Roche Chief Executive Officer and Chair of the Board of Directors			Adoption			December 3, 2025			Until May 3, 2027, or such earlier date upon which all transactions are completed or expire without execution			Sale of up to 120,000 shares

None of our officers or directors adopted or terminated a non-Rule 10b5-1 trading arrangement (as defined in Item 408(c) of Regulation S-K) during the first quarter of fiscal 2026.

Previous: Item 1A. Risk Factors · Next: Item 6. Exhibits